Methods and apparatus for renal neuromodulation

US8934978B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8934978-B2
Application numberUS-201414258802-A
CountryUS
Kind codeB2
Filing dateApr 22, 2014
Priority dateApr 8, 2002
Publication dateJan 13, 2015
Grant dateJan 13, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for treatment of a human patient diagnosed with hypertension, the method comprising: positioning a distal portion of a catheter within a renal artery and proximate to a renal nerve of the patient, wherein the catheter includes— a helical structure at the distal portion of the catheter, wherein the helical structure comprises a plurality of infusion ports or outlets, and wherein the helical structure is transformable between a low-profile delivery configuration and a deployed configuration sized and shaped to fit within the renal artery; and a plurality of electrodes carried by the helical structure; transforming the helical structure from the delivery configuration to the deployed configuration to place the electrodes in apposition with an inner wall of the renal artery; inhibiting neural communication along the renal nerve via radio frequency (RF) energy from the electrodes; and infusing a protective agent from the plurality of infusion ports or outlets into the renal artery before, during, and/or after delivery of RF energy from the electrodes. 2. The method of claim 1 wherein positioning a distal portion of a catheter within a renal artery comprises delivering the catheter over a guidewire. 3. The method of claim 1 , further comprising monitoring a parameter of the catheter and/or tissue within the patient before and during delivery of RF energy. 4. The method of claim 3 wherein the electrodes are dynamically assignable, and wherein the method further comprises altering delivery of RF energy to one or more of the electrodes in response to the monitored parameter. 5. The method of claim 1 wherein the electrodes are configured for monopolar RF energy delivery. 6. The method of claim 1 wherein the helical structure comprises five ring electrodes arranged thereon, and wherein each electrode is dynamically assignable. 7. The method of claim 1 wherein infusing a protective agent from the plurality of infusion ports or outlets into the renal artery comprises infusing a chilled fluid, saline, hypertonic saline, or heparinized saline, and/or an anti-proliferative agent. 8. The method of claim 1 wherein inhibiting neural communication along the renal nerve via RF energy comprises ablating the renal nerve of the patient. 9. The method of claim 1 wherein inhibiting neural communication along the renal nerve via RF energy comprises partially ablating the renal nerve of the patient. 10. The method of claim 1 wherein inhibiting neural communication along the renal nerve via RF energy comprises at least partially blocking afferent and efferent neural traffic to and/or from a kidney of the patient.

Assignees

Inventors

Classifications

  • having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence) · CPC title

  • Balloons · CPC title

  • Spinal or peripheral nerve electrodes · CPC title

  • Applying electric currents by contact electrodes · CPC title

  • adapted for stimulating afferent nerves · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8934978B2 cover?
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be effic…
Who is the assignee on this patent?
Deem Mark E, Gifford Iii Hanson, Zarins Denise, and 5 more
What technology area does this patent fall under?
Primary CPC classification A61B18/1492. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).